Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Clinical trial NCT00822848 · COMPLETED

Trial details

NCT number

NCT00822848

Sponsor

OHSU Knight Cancer Institute

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2009-02-01

Primary completion

2012-09-01

Enrollment

18

View on ClinicalTrials.gov